Dr Reddy’s Laboratories has signed an exclusive 10 year agreement with Germany-based Sygnis Pharma AG for the supply of an ingredient used in the treatment of stroke and other neurodegenrative disorders.
Dr Reddy’s Laboratories has signed an exclusive 10 year agreement with Germany-based Sygnis Pharma AG for the supply of an ingredient used in the treatment of stroke and other neurodegenrative disorders.